Upcoming Allied Market Research
Pharma 4.0 Market

Pharma 4.0 Market

by Design (Capabilities, Digital Maturity, Data Integrity), by Technology (Cyber-physical Systems, Big Data Analytics, Cloud Computing, Other) and by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A15441
Pages: NA
Jul 2023 | 1295 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pharma 4.0 Market

Request Now !

The four stages of manufacturing evolution have led us to Pharma 4.0. The phrase "Industries 4.0" was coined by the German federal government as part of a national effort to boost industry computerization. It is the fourth industrial revolution on the route to the Internet of Things (IoT), data, and services. Decentralized intelligence contributes to intelligent object networking and autonomous process management, with the interface of the real and virtual worlds being an important new feature of the manufacturing and production process.

The core idea is that connecting machines and systems can develop intelligent networks that control each other along the value chain. Machines, for example, would be able to detect faults and initiate repair processes on their own, as well as self-organized logistics that respond to changes in production. Pharma 4.0 technologies include big data, advanced analytics, virtual reality, cloud, the Internet of Things (IoT), and machine-to-machine communication (M2M).

COVID-19 Impact Analysis:

The COVID-19 pandemic has had a substantial impact on the major countries that are contributing to the industry 4.0 market. Various regions continue to be affected, and governments in these areas are responding to the pandemic in a variety of ways. The manufacturing industry is experiencing enormous hurdles as the COVID-19 pandemic rages in North America and developing Asian countries. Since the third quarter of 2020, the U.S. automotive sector, one of the world's largest, has been stagnant. Due to the decline in demand, several automobile companies reduced their manufacturing activities globally, rendering automation technologies such as the IoT, artificial intelligence, and blockchain utilized in these manufacturing units obsolete.

Top Impacting Factors:

  • The increase in the geriatric population causes a surge in chronic diseases such as cardiac disorders lead to the high demand for monitoring devices (ECG, BP, and glucose), which propels the growth of the pharma 4.0 market.
  • The rapid increase in the number of hospitals and clinical centers need rapid fault/mistake detection and also withdrawal of the technical drawback boost the market growth.
  • Moreover, healthcare systems based on the IoT help doctors to better control illnesses, track patients, and improve medical outcomes that boost the market. 
  • The increase in demand for personalized medicine surges the pharma 4.0 market.
  • In addition, the rapid adoption of Artificial Intelligence (AI) and Internet of Things (IoT) in the manufacturing sector because IoT in health care helps to reduce an item of expenditure, reduce time and effort, remote monitor patients to various physiological parameters, which fuel the pharma 4.0 market. 
  • However, the lack of a skilled workforce conversant with new developments in AI and IoT technologies is expected to restrain the market growth. 

Market Trends:

New Product Launches to Flourish Pharma 4.0 Market

In June 2019, CherryCircle Software announced significant new features, including process capability analytics, expanded support for Contract Development and Manufacturing Organizations (CDMOs and CMOs) and consultants, and data import capabilities for faster project setup and data ingestion. The company provides the QbDVision platform to accelerate the development of manufacturing processes for the pharmaceutical industry, which is the first-of-its-kind cloud solution for risk-based management of pharmaceutical process development. The platform captures and aggregates drug development knowledge over time for smarter development within a single, validated solution.

In September 2018, Vifor Pharma Group announced that the company and partner Goodly Innovations were awarded the 2018 Pharma 4.0 Award for the innovation of the year in manufacturing execution systems in the pharma industry. 

The number of deaths due to chronic and cardiovascular illnesses (CVDs) is increasing globally. According to the WHO, CVDs cause 17.9 million deaths per year. The IoT-powered electrocardiogram monitoring has the potential to significantly improve safety and well-being while also providing high-quality medical care. Aside from that, with the use of the IoT, it can knowingly cut the expense, travel, and also time in the remote and electrocardiogram monitoring. Therefore, CVDs will drive the pharma 4.0 market growth in the forecast period.

Key Benefits of Report:

  • This study presents the analytical depiction of the pharma 4.0 along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the pharma 4.0 market share.
  • The current market is quantitatively analyzed to highlight the pharma 4.0 market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed pharma 4.0 market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions Answered in Pharma 4.0 Market Report:

  • Who are the leading market players active in the pharma 4.0 market?
  • What current trends will influence the pharma 4.0 market in the next few years?
  • What are the driving factors, restraints, and opportunities in the pharma 4.0 market?
  • What future projections would help in taking further strategic steps?
  • What is pharma 4.0?
  • What is pharma 4.0 market prediction in the future?
  • Who are the leading global players in the pharma 4.0 market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the pharma 4.0 market report?

Pharma 4.0 Market Report Highlights

Aspects Details
By Design
  • Capabilities
  • Digital Maturity
  • Data Integrity
By Technology
  • Cyber-physical Systems
  • Big Data Analytics
  • Cloud Computing
  • Other
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Pfizer Inc, Vertex, Lonza Group AG, Medtronic Plc., Koninklijke Philips N.V., Boston Scientific, Johnson & Johnson, GE Healthcare, GlaxoSmithKline plc., Glatt GmbH, Abbott Laboratories

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.


Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Pharma 4.0 Market

Start reading.
This Report and over 53,601+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers